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Aconitase, the second enzyme of the tricarboxylic acid cycle encoded by ACO1 in the budding yeast Saccharomyces cerevisiae,
catalyzes the conversion of citrate to isocitrate. aco1Δ results in mitochondrial DNA (mtDNA) instability. It has been proposed that
Aco1 binds to mtDNA and mediates its maintenance. Here we propose an alternative mechanism to account for mtDNA loss in
aco1Δ mutant cells. We found that aco1Δ activated the RTG pathway, resulting in increased expression of genes encoding citrate
synthase. By deleting RTG1, RTG3, or genes encoding citrate synthase, mtDNA instability was prevented in aco1Δ mutant cells.
Increased activity of citrate synthase leads to iron accumulation in the mitochondria. Mutations in MRS3 and MRS4, encoding
two mitochondrial iron transporters, also prevented mtDNA loss due to aco1Δ. Mitochondria are the main source of superoxide
radicals, which are converted to H2 O2 through two superoxide dismutases, Sod1 and Sod2. H2 O2 in turn reacts with Fe2+ to generate
very active hydroxyl radicals. We found that loss of Sod1, but not Sod2, prevents mtDNA loss in aco1Δ mutant cells. We propose
that mtDNA loss in aco1Δ mutant cells is caused by the activation of the RTG pathway and subsequent iron citrate accumulation
and toxicity.

1. Introduction
Respiratory metabolism in eukaryotes requires proteins
encoded in both the nuclear genome and the mitochondrial
genome (mtDNA). Mitochondrial genomes generally encode
a small number of proteins, many of which are involved
in respiratory metabolism [1, 2]. Maintenance of mtDNA is
important for cell growth and survival. Oxidative damage to
mtDNA causes respiratory deficiency and human diseases
[3–5]. In higher eukaryotes, how the mitochondrial genome
is maintained and transmitted is not well understood. However, studies using the budding yeast Saccharomyces cerevisiae
have generated an abundance of data on how its mitochondrial genome is maintained [6, 7]. Many nuclear-encoded
proteins of diverse functions are required for mtDNA maintenance. When mtDNA is mutated, yeast cells form the socalled “petite” mutants. Yeast can be categorized as those with
wild type (rho+ cells), extensively deleted (rho− petites), or

with complete loss of (rho0 petites) mtDNA. How mutations
in nuclear genes cause defects in mtDNA maintenance is
complex and often indirect. For example, mutations in the
yeast homolog of frataxin, Yfh1, lead to iron overload in
mitochondria, defects in maturation of proteins containing
iron-sulfur clusters such as the TCA cycle enzyme aconitase,
mtDNA instability and respiratory deficiency, and so forth
[8–10]. Yeast studies have suggested that iron citrate toxicity
may be responsible for yfh1 mutant phenotypes [11, 12]. Respiratory metabolism generates reactive oxygen species such as
superoxide radicals. Superoxide dismutases, Sod1 and Sod2,
localized in the cytoplasm and mitochondria, respectively, are
responsible for converting superoxide radicals to relatively
harmless hydrogen peroxide [13], which can react with ferrous iron (Fe2+ ) to generate highly reactive hydroxyl radicals
through the Fenton reaction. Hydrogen peroxide is detoxified
by enzymes such as catalases, converting hydrogen peroxide
to oxygen and water [14]. Mutations in yeast catalases and
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superoxide dismutase lead to oxidative damage and reduced
resistance to oxidants [14–16].
Besides resulting in respiratory deficiency, mutations in
TCA cycle enzyme encoding genes also lead to variable
defects in mtDNA maintenance [17, 18]. The most severe phenotype is caused by mutations in the ACO1 gene encoding
aconitase, followed by the IDH1 gene encoding a subunit
of mitochondrial isocitrate dehydrogenase [19]. It has been
proposed that Aco1 has a novel function in mediating
mtDNA maintenance by directly binding mtDNA [20, 21].
Mutations in ACO1 and IDH1 share several growth defect
phenotypes, which can be partially rescued by mutations in
CIT1, encoding the mitochondrial isoform of citrate synthase
[17]. Expression of CIT1, ACO1, IDH1, and IDH2 is under dual
control of two transcriptional regulatory complexes, Rtg1/3
and Hap2/3/4/5 [22]. In cells with reduced or defective respiratory functions, expression of these genes is under increased
control of Rtg1/3. Rtg1 and Rtg3 are two basic helix-loophelix transcription factors in the retrograde response pathway
that mediates signaling from mitochondria to the nucleus
[23]. Activation of Rtg1/3 requires a cytoplasmic protein,
Rtg2, which has an N-terminal ATP binding domain in the
Hsp70/actin/sugar kinase ATP binding domain superfamily
[24]. The retrograde response pathway, also known as the
RTG pathway, is activated in response to defects in mitochondrial respiratory function. Cit1, Aco1, and Idh1/2 promote
synthesis of 𝛼-ketoglutarate, a precursor of glutamate, which
is a potent repressor of the RTG pathway [23]. Mutations in
ACO1, which lead to both a block in mitochondrial respiratory function and glutamate auxotrophy [25–27], therefore,
likely activate the RTG pathway. However, it is not clear
whether the RTG pathway contributes to the phenotypes of
aco1 mutants.
Mutations in RTG2 and CIT2 have been reported to
suppress mtDNA instability due to mutations in YFH1 [12].
In this study, we provide an alternative model to account for
mtDNA loss due to an aco1Δ mutation. We found that mutations in either RTG genes, genes encoding citrate synthases,
genes encoding mitochondrial iron transporters, or SOD1
suppress aco1Δ-induced mtDNA loss. Therefore, we propose
that iron citrate toxicity contributes to aco1Δ mutant phenotypes.

2. Materials and Methods
2.1. Strains, Plasmids, Growth Media, and Growth Conditions.
Yeast strains and plasmids used in this study are listed
in Tables 1 and 2, respectively. Yeast mutant strains were
created by either direct transformation with gene knockout cassettes or through meiotic segregation analysis of
heterozygous diploids. Mutations were confirmed by PCRgenotyping, standard genotyping based on selection markers,
phenotypic analysis, and/or immunoblotting using antibody
against Aco1. The BY4741 rho0 strain was generated by one
passage of rho+ cells grown in YPD medium supplemented
with 15 𝜇g/mL ethidium bromide. Yeast cells were grown in
SD (0.67% yeast nitrogen base plus 2% dextrose), YNBCasD
(SD medium plus 1% casamino acids), YNBcasR (0.67% yeast
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nitrogen base, 1% casamino acids, and 2% raffinose), YPD
(1% yeast extract, 2% peptone, 2% dextrose), or YPEthanol
(1% yeast extract, 2% peptone, 2% ethanol) medium at 30∘ C.
When necessary, amino acids, adenine, and/or uracil were
added to the growth medium at standard concentrations to
cover auxotrophic requirements [28].
2.2. Yeast Transformation and 𝛽-Galactosidase Activity Assays.
Plasmids were transformed into yeast strains using the highefficiency lithium acetate-PEG method and 𝛽-galactosidase
assays were carried out as described [28]. For each plasmid
and strain combination, assays were conducted in duplicates,
and independent experiments were carried out two times.
Specific activity of 𝛽-galactosidase is expressed as nmols of
𝑜-nitrophenol generated from substrate 𝑜-nitrophenyl-𝛽-Dgalactoside per min per mg protein.
2.3. DAPI Staining of Nuclear and Mitochondrial DNA and
FLuorescence Microscopy. DAPI (4 6,-diamidino-2-phenylindole) staining of nuclear and mitochondrial DNA was
carried out as described [28]. Briefly, yeast strains were grown
in liquid YPD or YNBcasD medium at 30∘ C overnight to
𝐴 600 ∼ 0.8. Cells were collected by centrifugation and treated
with 1 𝜇g/mL DAPI in 95% ethanol for 30 min and cell pellets
were washed with sterile water three times. DAPI-stained
DNA molecules in fixed cells were observed by fluorescence
microscopy using a Nikon Eclipse E800 microscope equipped
with an HBO 100 W/2 mercury arc lamp, a Nikon Plan Fluor
100X objective lens, and epifluorescence with a Nikon UV2E/C filter set (excitation 340–380 nm and emission 435–
485 nm). Digital images were acquired with Photometrics
Coolsnap fx CCD camera and Metamorph Imaging Software
(Molecular Devices, Sunnyvale, CA) and processed using
ImageJ (National Institutes of Health) and Adobe Photoshop
(Mountain View, CA).
2.4. Citrate Analysis. Cells were grown in 10 mL YPD
medium overnight to ∼OD600 1.0. Cultures were chilled in
ice-cold water for 22 min and cells were collected by centrifugation at 4∘ C. Cell pellets were then washed twice in chilled
water. Citrate levels were determined using a citrate assay kit
(BioVision, CA, USA). Cells were disrupted in 500 𝜇L Assay
Buffer in the kit using glass beads method. Cell extract was
clarified by centrifugation at 21,000 g at 4∘ C for 15 min. 20 uL
cell extract was analyzed for protein concentration using
Bradford assay and the rest of cell extract (∼350) was deproteinized in Amicon Ultra 4 column (10 kDa cutoff). Deproteinized extract was analyzed for citrate levels according to
the protocol provided by the manufacturer. Citrate levels in
different strains were normalized by protein concentration
of cellular extract prior to deproteinization. Citrate concentration in the wild-type strain was 7.97 nmols/mg proteins,
which was arbitrarily set as 1 unit. Citrate concentration in
the wild-type strain determined in this study is similar to
∼1.1 nmols/107 cells reported previously [12].
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Table 1: Strains used in this study.

Strain
BY4741
BY4731
BY4742
BY4741 (rho0 )
ZLY2630
ZLY1264
ZLY1267
ZLY1273
ZLY2568
ZLY143
ZLY2570
ZLY2648
ZLY2631
ZLY2652
ZLY3206
CS725-3A
ZLY2545
RBY353
RBY355
RBY356
ZLY2603
RBY469
RBY277
RBY363
ZLY854
BY4741 (mrs3 mrs4)
ZLY3505
ZLY4603
BY4741 (sod2)
TPY1507
ZLY3973

Genotype
MATa ura3 leu2 his3 met15
MATa ura3 leu2 met15
MATa ura3 leu2 his3 lys2
BY4741 rho0 derivative
BY4741 aco1::kanMX4
BY4741 rtg1::kanMX4
BY4741 rtg2::kanMX4
BY4741 rtg3::kanMX4
BY4742 rtg1::LEU2
BY4731 rtg2::LEU2
BY4742 rtg3::URA3
BY4741 rtg1::LEU2 aco1::kanMX4
BY4741 rtg2::LEU2 aco1::kanMX4
BY4741 rtg3::URA3 aco1::kanMX4
MAT𝛼 met? [rho0 ]
MATa ura3 leu2 his3 met15 cit1/2/3::kanMX4
CS725-3A aco1::HIS3
BY4741 cit1::kanMX4
BY4741 cit2::kanMX4
BY4741 cit3::kanMX4
MATa ura3 leu2 met15 aco1::kanMX4
BY4741 cit1::kanMX4 aco1::kanMX4
BY4741 cit2::kanMX4 aco1::kanMX4
BY4741 cit3::kanMX4 aco1::kanMX4
BY4741 cit1/2::kanMX4 aco1::kanMX4
BY4741 mrs3::kanMX4 mrs4::kanMX4
BY4741 mrs3::kanMX4 mrs4::kanMX4 aco1::HIS3
BY4741 sod1::kanMX4
BY4741 sod2::kanMX4
BY4741 sod1::kanMX4 aco1::kanMX4
BY4741 sod2::kanMX4 aco1::kanMX4

Source
Research genetics
Research genetics
Research genetics
This study
This study
Research genetics
Research genetics
Research genetics
This study
This study
This study
This study
This study
This study
This study
[21]
[21]
Research genetics
Research genetics
Research genetics
This study
This study
This study
This study
This study
[29]
This study
This study
Research genetics
This study
This study

Table 2: Plasmids used in this study.
Plasmid
pRS416
pUC-rtg1::LEU2
pUC-rtg2::LEU2
pUC-rtg3::URA3
pBS-aco1::HIS3
pCIT2-lacZ
pRS303-SOD1

Description
A yeast centromeric plasmid carrying URA3 selection marker
An rtg1::LEU2 disruption cassette in pUC19
An rtg2::LEU2 disruption cassette in pUC19
An rtg3::URA3 disruption cassette in pUC19
An aco1::HIS3disruption cassette in pBluescript
A CIT2-lacZ reporter gene on the plasmid pWCJ (CEN URA3)
The SOD1 gene was cloned into the integrative plasmid pRS303

3. Results and Discussion
3.1. aco1Δ Activates the RTG Pathway. Mutations in ACO1
lead to both respiratory deficiency and glutamate starvation,
which are expected to activate the RTG pathway. To test this
possibility, we determined the effect of an aco1Δ mutation on
the expression of a CIT2-lacZ reporter gene, which has been
used extensively as a readout of the activity of the RTG pathway [22, 24, 33–35]. Expression of CIT2-lacZ was assessed in

Source
[30]
[31]
[31]
[32]
This study
This study
This study

wild-type rho+ and aco1Δ mutant cells using 𝛽-galactosidase
assays. Since aco1Δ cells are rho0 petites, we also determined
CIT2-lacZ expression in otherwise wild-type rho0 cells. Cells
were grown in rich media with either raffinose or dextrose
(D-glucose) as the sole carbon source, which have been used
in studies on the RTG pathway and mitochondrial genome
maintenance, respectively [12, 20, 21, 36]. In cells grown in
raffinose medium, CIT2-lacZ expression was 4-fold higher in
rho0 cells compared to rho+ cells, consistent with previous
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Figure 1: The RTG pathway is activated in aco1Δ mutant cells grown
in dextrose medium. Wild-type rho+ (WT, BY4741), its rho0 derivative, and aco1Δ (ZLY2603) mutant strains were transformed with a
centromeric plasmid encoding a CIT2-lacZ reporter gene (pCIT2lacZ) and transformants were grown in YNBcasR (Raffinose) and
YNBcasD (Dextrose) medium to mid-logarithmic phase. Cells were
collected and 𝛽-galactosidase assays were conducted as described in
Section 2.

reports that the RTG pathway is activated in rho0 cells
[33, 36]. An aco1Δ mutation induced CIT2-lacZ expression
slightly higher than in wild-type rho0 cells (Figure 1). In cells
grown in dextrose medium, CIT2-lacZ expression in rho0
cells is only marginally higher than in rho+ cells, whereas
an aco1Δ mutation almost doubled CIT2-lacZ expression.
Activation of the RTG pathway is strain dependent [37]. The
lack of induction of the RTG pathway due to loss of mtDNA
in dextrose-grown BY4741 background strains used in this
study can be partly attributed to a doubling of CIT2-lacZ
expression in rho+ cells grown in this medium compared to
raffinose medium, which is consistent with activation of the
RTG pathway due to compromised mitochondrial respiratory
function since dextrose suppresses respiratory metabolism in
yeast. Altogether, these data indicate that an aco1Δ mutation
leads to activation of the RTG pathway.
3.2. Mutations in RTG Genes Prevent mtDNA Loss due to
aco1Δ. To determine whether activation of the RTG pathway
in aco1Δ mutant cells contributes to mtDNA loss, rtg1Δ
aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ double mutants were
constructed and examined for the presence or absence of
mtDNA. These double mutant strains were created by crossing respective haploid mutant strains to form heterozygous
diploid mutants, which were then sporulated to generate
desired haploid segregants. Seven rtg1Δ aco1Δ, seven rtg2Δ
aco1Δ, and six rtg3Δ aco1Δ double mutant segregants were
obtained. Eight aco1Δ single mutant segregants were also
isolated similarly. DAPI, a DNA-specific probe that forms a
fluorescent complex [38], was then used to visualize mtDNA
using fluorescence microscopy in these mutants along with

wild-type rho+ and rho0 strains. In addition to nuclear DNA,
DAPI staining revealed punctate cytoplasmic structures of
mtDNA in wild-type rho+ cells grown in YPD medium
(Figure 2(a)) [38]. In contrast, mtDNA was absent in both
wild-type rho0 and aco1Δ mutant cells, consistent with previous reports that Aco1 is required for mtDNA maintenance
[17, 18, 21]. Interestingly, mtDNA was maintained in rtg1Δ
aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ double mutant strains,
indicating that Rtg proteins mediate mtDNA instability in
aco1Δ mutant cells. The percentage of rho0 cells was quantified from DAPI-stained images and a large majority of rtgΔ
aco1Δ double mutant cells were found to contain mtDNA
(Figure 2(b)). Among seven rtg2Δ aco1Δ double mutant segregants from heterozygous rtg2Δ/RTG2 aco1Δ/ACO1 diploid
mutant cells, all were found to maintain mtDNA. Similarly,
all of the seven rtg1Δ aco1 and six rtg3Δ aco1Δ double mutant
segregants were also found to be rho+ cells. In contrast, all of
the eight aco1Δ single mutant segregants from a heterozygous
aco1Δ/ACO1 diploid mutant have lost mtDNA. Together, our
data suggest that mtDNA instability in aco1Δ mutant cells
may result from activation of the RTG pathway.
Damages to mtDNA can lead to extensive deletions
(rho− ) or point mutations (mit − ) [6, 7]. Yeast strains that
carry these two types of mutant mitochondrial genomes
are respiratory deficient. To determine whether the mtDNA
in the rtgΔ aco1Δ double mutant strains is functional, we
conducted a complementation assay by crossing wild-type
rho+ , wild-type rho0 , rtg1Δ, rtg2Δ, rtg3Δ, rtg1Δ aco1Δ, rtg2Δ
aco1Δ, and rtg3Δ aco1Δ mutant strains to a rho0 tester strain
of opposite mating type with wild-type nuclear ACO1 gene
and analyzing the respiratory capacity of the resultant diploid
strains. rtg1Δ aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ mutant
strains were unable to utilize carbon sources that require
respiratory metabolism such as ethanol because they are
defective in the TCA cycle (data not shown), and Figure 2(c)
shows that diploids generated from crossing wild-type rho+ ,
rtg1Δ, rtg2Δ, and rtg3Δ strains with the rho0 tester strain were
able to grow on ethanol medium. In contrast, diploids from
crosses involving wild-type rho0 or the aco1Δ single mutant
were unable to grow on ethanol medium, consistent with the
absence of mtDNA in these diploids. Remarkably, diploids
generated from the rho0 tester strain and rtgΔ aco1Δ double
mutants were able to grow on ethanol medium, indicating
that mtDNA in rtgΔ aco1Δ cells are functional.
3.3. Mutations in Genes Encoding Citrate Synthase, Primarily
CIT1, Prevent mtDNA Loss due to aco1Δ. What is the mechanism of aco1Δ suppression by mutations in RTG genes? The
RTG pathway is required for glutamate biosynthesis in cells
with reduced respiratory function by regulating expression of
CIT1, CIT2, ACO1, IDH1, and IDH2 [23]. It has been shown
previously that a cit1Δ mutation partially suppresses mtDNA
loss in aco1Δ mutant cells and that mutations in CIT2 and
RTG2 rescue respiratory deficiency in yfh1Δ mutant cells
[12, 17]. Three genes, CIT1, CIT2, and CIT3, encode citrate
synthase in yeast, with CIT1 and CIT3 encoding the two
mitochondrial isoforms and CIT2 encoding the peroxisomal
isoform [39–41]. Therefore, suppression of mtDNA loss in
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Figure 2: mtDNA is maintained in rtg1Δ aco1, rtg2Δ aco1Δ, and rtg3Δ aco1Δ mutant cells. (a) Cells grown exponentially in YPD medium
were stained with DAPI and then examined using fluorescence microscopy. WT (rho+ ), BY4741; WT (rho0 ), BY4741 rho0 ; aco1Δ, ZLY2630;
rtg1Δ aco1Δ, ZLY2648; rtg2Δ aco1Δ, ZLY2631; rtg3Δ aco1Δ, ZLY2652. (b) Quantitative analysis of the percentage of rho0 cells in yeast strains
based on DAPI-staining images. (c) mtDNA in rtgΔ aco1Δ double mutant cells is functional. Strains as described in (a) as well as rtg1Δ, rtg2Δ,
and rtg3Δ single mutants were crossed to a rho0 tester strain (X rho0 ) of opposite mating type. Diploids were selected and grown on YPD
(Dextrose) and YPEthanol (Ethanol) medium. Pictures of cells were taken after 3 days’ growth at 30∘ C.

rtg1Δ aco1Δ, rtg2Δ aco1Δ, and rtg3Δ aco1Δ double mutant
cells may be due to reduced expression of genes encoding
citrate synthase. To confirm this possibility, we introduced
an aco1Δ mutation into a cit1Δ cit2Δ cit3Δ triple mutant in
the BY4741 strain background generated by Chen et al. [21].
The presence or absence of mtDNA in the resultant quadruple
mutant cells was examined by DAPI staining and fluorescence microscopy. Figure 3(a) shows that the cit1Δ cit2Δ cit3Δ
aco1Δ quadruple mutant maintained mtDNA. To determine
which citrate synthase-encoding gene(s) is responsible for
mtDNA loss in aco1Δ mutant cells, we generated cit1Δ aco1Δ,

cit2Δ aco1Δ, and cit3Δ aco1Δ double mutants, as well as an
aco1Δ cit1Δ cit2Δ triple mutant by crossing respective haploid
mutant strains followed by meiotic segregation analysis.
Using DAPI staining and fluorescence microscopy, we found
that six out of eight cit1Δ aco1Δ double mutants, zero out of
six cit2Δ aco1Δ double mutants, zero out of six cit3Δ aco1Δ
double mutants, and six out of six cit1Δ cit2Δ aco1Δ triple
mutant strains maintained mtDNA (Figure 3 and data not
shown). We also calculated the percentage of rho0 cells in
a cit1Δ aco1Δ double, a cit1Δ cit2Δ aco1Δ triple, and a cit1Δ
cit2Δ cit3Δ aco1Δ quadruple mutant and found that over 90%
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Figure 3: Mutations in genes encoding citrate synthase prevent mtDNA loss due to aco1Δ. (a) Cells grown in YPD medium to mid-logarithmic
phase were stained with DAPI and examined using fluorescence microscopy. WT (rho+ ), BY4741; aco1Δ, ZLY2630; cit1Δ aco1Δ, RBY469; cit2Δ
aco1Δ, RBY277; cit1Δ cit2Δ aco1Δ, ZLY854; cit1Δ cit2Δ cit3Δ aco1Δ, ZLY854; rtg2Δ aco1Δ, ZLY2545. (b) Quantitative analysis of the percentage
of rho0 cells in yeast strains based on DAPI-staining images.

WT (rho+ )

aco1Δ

mrs3Δ mrs4Δ aco1Δ

Figure 4: Mutations in MRS3 and MRS4, encoding mitochondrial
iron transporters, prevent mtDNA loss due to aco1Δ. Cells grown
in YPD medium to mid-logarithmic phase were stained with DAPI
and examined using fluorescence microscopy. WT (rho+ ), BY4741;
aco1Δ, ZLY2630; mrs3Δ mrs4Δ aco1Δ, ZLY3505.

cells from these mutants maintained mtDNA (Figure 3(b)).
Taken together, these data suggest that citrate synthase is the
target of the RTG pathway that mediates mtDNA instability
in aco1Δ mutant cells and that Cit1 is primarily responsible
for this phenotype in the BY4741 strain background.
3.4. Mutations in Genes Encoding Mitochondrial Iron Transporters Mrs3 and Mrs4 Prevent mtDNA Loss due to aco1Δ.
It has been proposed that iron citrate toxicity contributes
to oxidative damage and mtDNA loss in yfh1Δ mutant cells,
which have higher levels of cellular and mitochondrial iron
[8, 12]. Mutations in RTG2 and CIT2 reduce petite formation

in yfh1Δ mutants by lowering cellular citrate and iron levels. Suppression of mtDNA loss in aco1Δ mutant cells by
mutations in RTG genes and genes encoding citrate synthase
prompted us to test whether mitochondrial iron overload is
responsible for mtDNA instability in aco1Δ mutants. Mitochondrial iron transport is mediated by iron transporters
Mrs3 and Mrs4 [11, 29, 42, 43], mutations of which rescue
mtDNA loss in yfh1Δ mutants. To this end, we generated an
mrs3Δ mrs4Δ aco1Δ triple mutant by introducing an aco1Δ
mutation into an mrs3Δ mrs4Δ double mutant. DAPI staining
of the triple mutant showed that mtDNA was maintained
(Figure 4). Furthermore, quantitative analysis showed that
the percentage of rho0 cells in the triple mutant was 0.4%,
slightly lower than 2.5% in wild-type rho+ cells. The mrs3Δ
mrs4Δ aco1Δ triple mutant was also mated to a rho0 tester
strain and the resulting diploids were streaked onto plates
with ethanol as the sole carbon source. We found that the
diploids could grow on ethanol medium, indicating that
mtDNA in the mrs3Δ mrs4Δ aco1Δ triple mutant is functional
(data not shown). Together, this data supports the notion
that mtDNA loss in aco1Δ mutant cells is due to iron citrate
toxicity.
It has been reported that the supplementation of exogenous iron (1 mM FeSO4 ) or raising pH of the growth medium
reduces petite frequency in aco1Δ mutant cells grown in
YPGalactose medium [17]. Thus, Lin et al. proposed that
some of the effects of elevated citrate levels in aco1Δ are
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Figure 5: Citrate levels in wild-type (WT) and indicated mutant
strains. Citrate concentration was determined as described in
Section 2. The results are the average of two independent experiments.
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Figure 6: A mutation in SOD1, but not SOD2, suppresses mtDNA
loss due to aco1Δ. Cells grown in YPD medium to mid-logarithmic
phase were stained with DAPI and examined using fluorescence
microscopy. aco1Δ, ZLY2630; sod1Δ aco1Δ, TPY1507; sod2Δ aco1Δ,
ZLY3973.

due to the ionized form of this metabolite rather than to
the formation of a citrate/iron chelate that could produce
oxidative damage to mtDNA. These observations seem to
contradict our conclusion. However, iron homeostasis is
a highly complicated process [44]. It was not established
that exogenous iron actually increased iron levels in the
mitochondria in Lin et al.’s study. It is also possible that
growth conditions (YPD in this study versus YPGalactose in
Lin et al.’s study) and/or strain backgrounds (BY4741 versus
W303-1B) may affect mtDNA loss associated with aco1Δ
mutations.
3.5. Iron Citrate Toxicity Correlates with mtDNA Loss in
aco1Δ Mutant Cells. To affirm our hypothesis that iron citrate
toxicity contributes to mtDNA loss in aco1Δ mutant cells,
we determined citrate levels in wild-type and various mutant
strains and found that aco1Δ increased the citrate level by

10.5-fold (Figure 5), which is consistent with an 11.9-fold
increase reported by Lin et al. [17]. This increase is not due
to that aco1Δ mutants are rho0 cells since the citrate level
in wild-type rho0 cells was only 16% higher than that of
wild-type rho+ cells. Mutations in RTG1, RTG2, and RTG3
reduced citrate levels in aco1Δ background cells by 59–85%.
Similarly, cit1Δ reduced citrate concentration by 62% in aco1Δ
background cells, which is comparable to an 89% decrease
reported by Lin et al. A double mutation in CIT1 and CIT2
reduced citrate concentration by 98% in aco1Δ background
cells, and an additional mutation in CIT3 did not significantly
further reduce citrate levels. Clearly, there is strong correlation between the suppression of mtDNA loss phenotype
and lower citrate levels in aco1Δ background strains. We also
determined the effect of an mrs3Δ mrs4Δ double mutation
on citrate levels. In comparison to a wild-type rho+ strain,
citrate concentration in an mrs3Δ mrs4Δ double mutant was
53% lower. In contrast, citrate concentration in an mrs3Δ
mrs4Δ aco1Δ triple mutant is 24% higher than that of an aco1Δ
mutant. Since mrs3Δ mrs4Δ aco1Δ mutant cells maintained
mtDNA, we propose that high levels of citrate per se are
not sufficient to lead to mtDNA loss and that citrate toxicity
requires certain levels of iron in the mitochondria. Together
with our genetic data, these biochemical results suggest that
iron citrate toxicity accounts for mtDNA loss in aco1Δ mutant
cells.
3.6. A Mutation in SOD1, but Not SOD2, Prevents mtDNA
Loss due to aco1Δ. Our data suggest that high levels of citrate
cause mtDNA instability in aco1Δ mutant cells likely due
to iron citrate toxicity. Iron reacts with hydrogen peroxide
in the Fenton reaction to produce highly active, potent
hydroxyl radicals, which cause oxidative damage to mitochondria. Hydrogen peroxide is partly produced by the
superoxide dismutases, Sod1 in the cytoplasm and Sod2 in the
mitochondrial matrix [12]. We hypothesized that a reduced
production of hydrogen peroxide due to mutations in SOD1
or SOD2 might suppress mtDNA loss in aco1Δ mutant cells
by lowering the amount of hydroxyl radicals produced via
the Fenton reaction. Therefore, we generated sod1Δ aco1Δ and
sod2Δ aco1Δ double mutants by crossing respective haploid
mutant strains followed by meiotic segregation analysis. The
resultant double mutant strains were analyzed for mtDNA
presence by DAPI staining and fluorescence microscopy.
33 out of 34 sod1Δ aco1Δ double mutant strains generated
maintained mtDNA while 6 out of 6 sod2Δ aco1Δ double
mutants lost mtDNA (Figure 6 and data not shown). These
data suggest that hydrogen peroxide generated from reactions
catalyzed by Sod1 contributes to mtDNA loss in aco1Δ mutant
cells. Mutations in SOD1 also cause oxidative damage due
to accumulation of superoxide radicals [15, 16]. However,
since an sod1Δ mutation suppressed mtDNA loss in aco1Δ
mutant cells, we propose that hydroxyl radicals are more
damaging to mtDNA than superoxide radicals. How would
mutations in the cytosolic isoform of superoxide dismutase
rescue a mitochondrial defect? It has been shown that a small
fraction of Sod1 is localized in the intermembrane space
of mitochondria, which protects cells from mitochondrial
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oxidative damage [45–47]. Why does not sod2Δ suppress
mtDNA loss associated with aco1Δ? It is possible that loss of
Sod2 leads to increased levels of superoxide radicals in the
mitochondria, which in the presence of ferrous ions would
cause any hydrogen peroxide produced in the mitochondria
to be converted to the hydroxyl radicals via the Fenton/Haber
Weiss reactions that damage mtDNA.
3.7. Loss of mtDNA in aco1Δ Mutant Cells Is Growth Medium
Dependent. It has been proposed that mtDNA loss in aco1Δ
mutant cells is due to lack of physical protection of mtDNA
by Aco1 [20]. One key piece of evidence that supports this
hypothesis is the observation that the expression of two
catalytically inactive Aco1 mutants, Aco1𝐶382𝑆 and Aco1𝐶445𝑆 ,
under the control of the ADH1 promoter from the pRS416
centromeric plasmid, prevented mtDNA loss in aco1Δ mutant
cells. To maintain the plasmids, transformants were grown
in YNBcasD medium. In light of discovery that iron citrate
toxicity contributes to mtDNA loss, one alternative explanation for mtDNA retention in cells expressing ACO1𝐶382𝑆
and ACO1𝐶445𝑆 mutant alleles is due to differences in growth
medium, YNBcasD versus YPD. Accordingly, we transformed aco1Δ/ACO1 heterozygous diploid mutant cells with
empty pRS416 vector and transformants were sporulated
and dissected on YPD or YNBcasD medium. Eleven aco1Δ
haploid mutants from a YPD dissection plate were obtained
and grown in YPD liquid medium and mtDNA was observed
by DAPI staining. We found that all of the eleven aco1Δ segregants lost mitochondrial DNA (Figure 7 and data not shown).
In contrast, among nine aco1Δ mutant segregants carrying the
empty pRS416 vector from a YNBcasD dissection plate that
were grown in YNBcasD liquid medium, seven maintained
mtDNA (Figure 7 and data not shown). When these seven
aco1Δ mutants containing mtDNA were passed onto YPD
plate medium twice and then grown in YPD liquid medium,
all lost mtDNA (data not shown). Together, these data suggest
that mtDNA loss in aco1Δ mutant cells is growth medium
dependent.

4. Conclusions
It has been proposed that yeast aconitase (Aco1) physically
binds to mtDNA and promotes its maintenance [20, 21]. Our
results in this study suggest a different, but not necessarily mutually exclusive, mechanism. We propose that aco1Δ
activates the RTG pathway, resulting in increased citrate
production through upregulation of genes encoding citrate
synthase. Increased levels of citrate lead to iron overload in
the mitochondria. Iron then reacts with hydrogen peroxide
to generate hydroxyl radicals, which cause oxidative damage
to mitochondrial DNA and consequently its instability. Mutations of yeast frataxin (Yfh1) lead to loss of activity of aconitase [48]. Suppression of mtDNA instability due to mutations
in both YFH1 and ACO1 by reduced iron citrate levels raises
the possibility that mtDNA loss in yfh1 mutant cells may be an
indirect consequence of aconitase inactivation. Our data also
suggest that the cytosolic superoxide dismutase, Sod1, but not

Oxidative Medicine and Cellular Longevity

aco1Δ (YNBCasD)

aco1Δ (YPD)

Figure 7: mtDNA loss due to aco1Δ is growth medium dependent.
aco1Δ mutant cells (ZLY2630) carrying empty pRS416 vector were
grown in YNBcasD or YPD medium to mid-logarithmic phase,
stained with DAPI, and examined using fluorescence microscopy.

the mitochondrial superoxide dismutase, Sod2, contributes
to mtDNA loss in aco1Δ mutant cells.
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and M. Koenig, “Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin,” Nature
Genetics, vol. 16, no. 4, pp. 345–351, 1997.
[10] R. B. Wilson and D. M. Roof, “Respiratory deficiency due to loss
of mitochondrial dna in yeast lacking the frataxin homologue,”
Nature Genetics, vol. 16, no. 4, pp. 352–357, 1997.
[11] F. Foury and T. Roganti, “Deletion of the mitochondrial carrier
genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain,” Journal of Biological
Chemistry, vol. 277, no. 27, pp. 24475–24483, 2002.
[12] O. S. Chen, S. Hemenway, and J. Kaplan, “Genetic analysis of
iron citrate toxicity in yeast: implications for mammalian iron
homeostasis,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 99, no. 26, pp. 16922–16927,
2002.
[13] V. C. Culotta, “Superoxide dismutase, oxidative stress, and cell
metabolism,” Current Topics in Cellular Regulation C, vol. 36, pp.
117–132, 2001.
[14] C. M. Grant, G. Perrone, and I. W. Dawes, “Glutathione and
catalase provide overlapping defenses for protection against
hydrogen peroxide in the yeast Saccharomyces cerevisiae,” Biochemical and Biophysical Research Communications, vol. 253, no.
3, pp. 893–898, 1998.
[15] O. Bermingham-McDonogh, E. B. Gralla, and J. S. Valentine,
“The copper, zinc-superoxide dismutase gene of Saccharomyces
cerevisiae: cloning, sequencing, and biological activity,” Proceedings of the National Academy of Sciences of the United States
of America, vol. 85, no. 13, pp. 4789–4793, 1988.
[16] X. F. Liu, I. Elashvili, E. B. Gralla, J. S. Valentine, P. Lapinskas,
and V. C. Culotta, “Yeast lacking superoxide dismutase. Isolation of genetic suppressors,” Journal of Biological Chemistry, vol.
267, no. 26, pp. 18298–18302, 1992.
[17] A. Lin, K. W. Hakala, S. T. Weintraub, and L. McAlister-Henn,
“Suppression of metabolic defects of yeast isocitrate dehydrogenase and aconitase mutants by loss of citrate synthase,” Archives
of Biochemistry and Biophysics, vol. 474, no. 1, pp. 205–212, 2008.
[18] M. T. McCammon, C. B. Epstein, B. Przybyla-Zawislak, L.
McAlister-Henn, and R. A. Butow, “Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and
oxidative genes,” Molecular Biology of the Cell, vol. 14, no. 3, pp.
958–972, 2003.
[19] M. Merkel and J. Kretowicz, “Sensitivity to natamycin in vitro
evaluation of Candida spp. and Torulopsis glabrata isolated
from vagina,” Polski Tygodnik Lekarski, vol. 40, no. 9, pp. 257–
258, 1985.
[20] X. J. Chen, X. Wang, and R. A. Butow, “Yeast aconitase binds and
provides metabolically coupled protection to mitochondrial
DNA,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 104, no. 34, pp. 13738–13743, 2007.
[21] X. J. Chen, X. Wang, B. A. Kaufman, and R. A. Butow, “Aconitase
couples metabolic regulation to mitochondrial DNA maintenance,” Science, vol. 307, no. 5710, pp. 714–717, 2005.
[22] Z. Liu and R. A. Butow, “A transcriptional switch in the expression of yeast tricarboxylic acid cycle genes in response to a
reduction or loss of respiratory function,” Molecular and Cellular Biology, vol. 19, no. 10, pp. 6720–6728, 1999.
[23] Z. Liu and R. A. Butow, “Mitochondrial retrograde signaling,”
Annual Review of Genetics, vol. 40, pp. 159–185, 2006.

9
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[27] C. Vélot, P. Haviernik, and G. J.-M. Lauquin, “The Saccharomyces cerevisiae RTG2 gene is a regulator of aconitase expression under catabolite repression conditions,” Genetics, vol. 144,
no. 3, pp. 893–903, 1996.
[28] D. C. Amberg, D. J. Burke, and J. N. Strathern, Methods in Yeast
Genetics: A Cold Spring Harbor Laboratory Course Manual, Cold
Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, 2005.
[29] L. Li and J. Kaplan, “A mitochondrial-vacuolar signaling pathway in yeast that affects iron and copper metabolism,” Journal
of Biological Chemistry, vol. 279, no. 32, pp. 33653–33661, 2004.
[30] R. S. Sikorski and P. Hieter, “A system of shuttle vectors and
yeast host strains designed for efficient manipulation of DNA
in Saccharomyces cerevisiae,” Genetics, vol. 122, no. 1, pp. 19–27,
1989.
[31] B. A. Rothermel, A. W. Shyjan, J. L. Etheredge, and R. A. Butow,
“Transactivation by Rtg1p, a basic helix-loop-helix protein that
functions in communication between mitochondria and the
nucleus in yeast,” Journal of Biological Chemistry, vol. 270, no.
49, pp. 29476–29482, 1995.
[32] Y. Jia, B. Rothermel, J. Thornton, and R. A. Butow, “A basic helixloop-helix-leucine zipper transcription complex in yeast functions in a signaling pathway from mitochondria to the nucleus,”
Molecular and Cellular Biology, vol. 17, no. 3, pp. 1110–1117, 1997.
[33] A. Chelstowska, Z. Liu, Y. Jia, D. Amberg, and R. A. Butow,
“Signalling between mitochondria and the nucleus regulates the
expression of a new D-lactate dehydrogenase activity in yeast,”
Yeast, vol. 15, no. 13, pp. 1377–1391, 1999.
[34] Z. Liu, T. Sekito, C. B. Epstein, and R. A. Butow, “RTGdependent mitochondria to nucleus signaling is negatively regulated by the seven WD-repeat protein Lst8p,” EMBO Journal,
vol. 20, no. 24, pp. 7209–7219, 2002.
[35] T. Sekito, Z. Liu, J. Thornton, and R. A. Butow, “RTG-dependent
mitochondria-to-nucleus signaling is regulated by MKS1 and is
linked to formation of yeast prion [URE3],” Molecular Biology
of the Cell, vol. 13, no. 3, pp. 795–804, 2002.
[36] X. Liao, W. C. Small, P. A. Srere, and R. A. Butow, “Intramitochondrial functions regulate nonmitochondrial citrate synthase
(CIT2) expression in Saccharomyces cerevisiae,” Molecular and
Cellular Biology, vol. 11, no. 1, pp. 38–46, 1991.
[37] P. A. Kirchman, S. Kim, C. Lai, and S. Michal Jazwinski, “Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae,” Genetics, vol. 152, no. 1, pp. 179–190, 1999.
[38] D. H. Williamson and D. J. Fennell, “Visualization of yeast
mitochondrial dna with the fluorescent stain ‘DAPI’,” Methods
in Enzymology C, vol. 56, pp. 728–733, 1979.
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